4
Participants
Start Date
August 31, 2014
Primary Completion Date
May 21, 2017
Study Completion Date
May 21, 2017
Pre-Post Feasibility
The feasibility testing phase will include 25 subjects. Total duration of pre-post feasibility testing will be 6 weeks upon retrieval of the RA-CBT tablet and follow up questionnaires, quantitative exit interview, and/or an optional extended qualitative exit interview. The extended exit interview is a qualitative semi-formal interview focusing on gathering participant experiences working with the intervention, the barriers and facilitators encountered, as well as overall feedback for the pre-post feasibility study and the relational agent.
Boston Medical Center, Boston
Lead Sponsor
Northeastern University
OTHER
Boston Medical Center
OTHER